Cardiawave was created at the end of 2014 as a result of a partnership of over 6 years between the team at the Langevin Institute, a world leader in ultrasound imaging and therapy, and the team at the Georges Pompidou European Hospital (HEGP), a leader in the field of valve disease and cardiac ultrasound imaging.
Led by an experienced management team, 2017 Prizewinner of Worldwide Innovation Contest 3rd phase, Cardiawave has secured over €14m since inception, to develop its product and to pursue preclinical studies before first-in-man expected in 2019.
Our device has been successfully tested in vitro and in vivo on large animal models. A first paper was published in JACC: Villemain, O., Robin, J., Bel, A., et al. Pulsed cavitational ultrasound softening: a new noninvasive therapeutic approach for calcified bioprosthetic valve stenosis, JACC: Basic to Translational Science, 2 (2017), pp. 372-383.
Awards & Honours:
2018 Prize-winner of SME Instrument, Phase 2 – European Union
2017 Prize-winner of Worldwide Innovation Contest (CMI), 3rd phase – French government / BPI France
2015 Prize-winner of Worldwide Innovation Contest (CMI), 2nd phase – French government / BPI France
2015 Prize winner of Fondation pour l’Innovation Thérapeutique Béatrice Denys – Turenne Capital (French Investment Fund)
2014 Prize-winner of Worldwide Innovation Contest (CMI), 1st phase – French government / BPI France
2014 Prize-winner of the French National Contest for Innovative Technologies Companies – French government / BPI France
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2014
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Cardiawave founded?
Cardiawave was founded in 2014.
What industry is Cardiawave in?
Cardiawave operates in Medical Devices. Find similar Medical Devices investors on gritt.io.
Where is Cardiawave based?
Cardiawave is headquartered in PARIS, France.
Find investors for your startup like Cardiawave
Gritt sends AI-personalised outreach to each investor — from your Gmail